Amgen Stock Target Price and Analyst Consensus

AMGN Stock  USD 369.70  3.50  0.96%   
The current analyst and expert consensus on Amgen is Buy with 14 hold recommendations. The current projected Amgen target price consensus is 343.96 with 32 analyst opinions. One of the most common ways Amgen Inc analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amgen vendors, executives, and/or customers. Amgen recommendation module provides expert sentiment on the projected Amgen Inc target price to derive its highest and lowest estimates based on target price standard deviation of 1.9524.
Lowest Forecast
313.01
Highest Forecast
381.8
Target Price
343.96
As of the 13th of February 2026, Gross Profit is likely to grow to about 31.8 B, while Pretax Profit Margin is likely to drop 0.24. At this time, Amgen's Net Debt is very stable compared to the past year. As of the 13th of February 2026, Cash is likely to grow to about 9.6 B, though Retained Earnings are likely to grow to (23.6 B).
It's important to approach Amgen's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Amgen Target Price Consensus

Amgen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amgen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   32  Buy
Most Amgen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amgen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amgen Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Amgen Target Price Projection

Amgen's current and average target prices are 369.70 and 343.96, respectively. The current price of Amgen is the price at which Amgen Inc is currently trading. On the other hand, Amgen's target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Amgen Market Quote on 13th of February 2026

Low Price366.2Odds
High Price369.7Odds

369.7

Target Price

Analyst Consensus On Amgen Target Price

Low Estimate313.01Odds
High Estimate381.8Odds

343.963

Historical Lowest Forecast  313.01 Target Price  343.96 Highest Forecast  381.8
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Amgen Inc and the information provided on this page.

Amgen Analyst Ratings

Amgen's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amgen stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amgen's financials, market performance, and future outlook by experienced professionals. Amgen's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Amgen price targets

Amgen's stock target price is an estimate of its future price, usually made by analysts. Using Amgen's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Amgen's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amgen's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Amgen Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amgen is a key component of Amgen valuation and have some predictive power on the future returns of a Amgen.
Hype
Prediction
LowEstimatedHigh
332.73371.85373.80
Details
Intrinsic
Valuation
LowRealHigh
367.99369.94371.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
4.175.166.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amgen. Your research has to be compared to or analyzed against Amgen's peers to derive any actionable benefits. When done correctly, Amgen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amgen Inc.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 90 shares
ESG Investing Idea
ESG Investing
Sold few shares
Millennials Best Idea
Millennials Best
Invested over 90 shares
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Macroaxis Advice on Amgen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.